473 related articles for article (PubMed ID: 29400072)
21. Pathological mechanisms of human T-cell lymphotropic virus type I-associated myelopathy (HAM/TSP).
Osame M
J Neurovirol; 2002 Oct; 8(5):359-64. PubMed ID: 12402162
[TBL] [Abstract][Full Text] [Related]
22. Tropical spastic paraparesis/human T leukemia virus type 1-associated myelopathy in HIV type 1-coinfected patients.
Beilke MA; Japa S; Moeller-Hadi C; Martin-Schild S
Clin Infect Dis; 2005 Sep; 41(6):e57-63. PubMed ID: 16107970
[TBL] [Abstract][Full Text] [Related]
23. Human T-lymphotropic virus 1 (HTLV-1)-associated lichenoid dermatitis induced by CD8+ T cells in HTLV-1 carrier, HTLV-1-associated myelopathy/tropical spastic paraparesis and adult T-cell leukemia/lymphoma.
Tokura Y; Ito T; Kawakami C; Sugita K; Kasuya A; Tatsuno K; Sawada Y; Nakamura M; Shimauchi T
J Dermatol; 2015 Oct; 42(10):967-74. PubMed ID: 26077665
[TBL] [Abstract][Full Text] [Related]
24. Mogamulizumab, an anti-CCR4 antibody, targets human T-lymphotropic virus type 1-infected CD8+ and CD4+ T cells to treat associated myelopathy.
Yamauchi J; Coler-Reilly A; Sato T; Araya N; Yagishita N; Ando H; Kunitomo Y; Takahashi K; Tanaka Y; Shibagaki Y; Nishioka K; Nakajima T; Hasegawa Y; Utsunomiya A; Kimura K; Yamano Y
J Infect Dis; 2015 Jan; 211(2):238-48. PubMed ID: 25104771
[TBL] [Abstract][Full Text] [Related]
25. In vivo proviral burden and viral RNA expression in T cell subsets of patients with human T lymphotropic virus type-1-associated myelopathy/tropical spastic paraparesis.
Cho I; Sugimoto M; Mita S; Tokunaga M; Imamura F; Ando M
Am J Trop Med Hyg; 1995 Oct; 53(4):412-8. PubMed ID: 7485696
[TBL] [Abstract][Full Text] [Related]
26. Blockade of IL-2 receptor suppresses HTLV-I and IFN-gamma expression in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis.
Fukushima N; Nishiura Y; Nakamura T; Kohno S; Eguchi K
Intern Med; 2007; 46(7):347-51. PubMed ID: 17409595
[TBL] [Abstract][Full Text] [Related]
27. Tax secretion from peripheral blood mononuclear cells and Tax detection in plasma of patients with human T-lymphotropic virus-type 1-associated myelopathy/tropical spastic paraparesis and asymptomatic carriers.
Medina F; Quintremil S; Alberti C; Godoy F; Pando ME; Bustamante A; Barriga A; Cartier L; Puente J; Tanaka Y; Valenzuela MA; Ramírez E
J Med Virol; 2016 Mar; 88(3):521-31. PubMed ID: 26241614
[TBL] [Abstract][Full Text] [Related]
28. HTLV-1 induces a Th1-like state in CD4
Yamano Y; Coler-Reilly A
J Neuroimmunol; 2017 Mar; 304():51-55. PubMed ID: 27542993
[TBL] [Abstract][Full Text] [Related]
29. High IFN-γ/IL-10 expression ratio and increased frequency of persistent human T-cell lymphotropic virus type 1-infected clones are associated with human T-cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis development.
Espíndola OM; Oliveira LC; Ferreira PM; Leite AC; Lima MA; Andrada-Serpa MJ
Intervirology; 2015; 58(2):106-14. PubMed ID: 25833232
[TBL] [Abstract][Full Text] [Related]
30. Programmed death-1 (PD-1)/PD-1 ligand pathway-mediated immune responses against human T-lymphotropic virus type 1 (HTLV-1) in HTLV-1-associated myelopathy/tropical spastic paraparesis and carriers with autoimmune disorders.
Kozako T; Yoshimitsu M; Akimoto M; White Y; Matsushita K; Soeda S; Shimeno H; Kubota R; Izumo S; Arima N
Hum Immunol; 2011 Nov; 72(11):1001-6. PubMed ID: 21851845
[TBL] [Abstract][Full Text] [Related]
31. HTLV-I proviral DNA amount correlates with infiltrating CD4+ lymphocytes in the spinal cord from patients with HTLV-I-associated myelopathy.
Kubota R; Umehara F; Izumo S; Ijichi S; Matsumuro K; Yashiki S; Fujiyoshi T; Sonoda S; Osame M
J Neuroimmunol; 1994 Aug; 53(1):23-9. PubMed ID: 7914211
[TBL] [Abstract][Full Text] [Related]
32. Demonstration of human T lymphotropic virus type I (HTLV-I) tax-specific CD8+ lymphocytes directly in peripheral blood of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by intracellular cytokine detection.
Kubota R; Kawanishi T; Matsubara H; Manns A; Jacobson S
J Immunol; 1998 Jul; 161(1):482-8. PubMed ID: 9647259
[TBL] [Abstract][Full Text] [Related]
33. Pentosan Polysulfate Demonstrates Anti-human T-Cell Leukemia Virus Type 1 Activities
Ma G; Yasunaga JI; Ohshima K; Matsumoto T; Matsuoka M
J Virol; 2019 Aug; 93(16):. PubMed ID: 31167921
[TBL] [Abstract][Full Text] [Related]
34. Possible implication of NFKB1A and NKG2D genes in susceptibility to HTLV-1-associated myelopathy/tropical spastic paraparesis in Peruvian patients infected with HTLV-1.
Talledo M; López G; Huyghe JR; Verdonck K; González E; Clark D; Vanham G; Gotuzzo E; Van Camp G; Van Laer L
J Med Virol; 2012 Feb; 84(2):319-26. PubMed ID: 22170554
[TBL] [Abstract][Full Text] [Related]
35. Protein Profile of Blood Monocytes is Altered in HTLV-1 Infected Patients: Implications for HAM/TSP Disease.
Echevarria-Lima J; de Abreu Pereira D; de Oliveira TS; de Melo Espíndola O; Lima MA; Celestino Leite AC; Sandim V; Rodrigues Nascimento C; E Kalume D; B Zingali R
Sci Rep; 2018 Sep; 8(1):14354. PubMed ID: 30254298
[TBL] [Abstract][Full Text] [Related]
36. An insight to HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) pathogenesis; evidence from high-throughput data integration and meta-analysis.
Mozhgani SH; Piran M; Zarei-Ghobadi M; Jafari M; Jazayeri SM; Mokhtari-Azad T; Teymoori-Rad M; Valizadeh N; Farajifard H; Mirzaie M; Khamseh A; Rafatpanah H; Rezaee SA; Norouzi M
Retrovirology; 2019 Dec; 16(1):46. PubMed ID: 31888669
[TBL] [Abstract][Full Text] [Related]
37. Multistability in a model for CTL response to HTLV-I infection and its implications to HAM/TSP development and prevention.
Gómez-Acevedo H; Li MY; Jacobson S
Bull Math Biol; 2010 Apr; 72(3):681-96. PubMed ID: 20041353
[TBL] [Abstract][Full Text] [Related]
38. Target epitopes of HTLV-1 recognized by class I MHC-restricted cytotoxic T lymphocytes in patients with myelopathy and spastic paraparesis and infected patients with autoimmune disorders.
Kozako T; Akimoto M; Toji S; White Y; Suzuki S; Arima T; Suruga Y; Matsushita K; Shimeno H; Soeda S; Kubota R; Izumo S; Uozumi K; Arima N
J Med Virol; 2011 Mar; 83(3):501-9. PubMed ID: 21264872
[TBL] [Abstract][Full Text] [Related]
39. Virological aspects of tropical spastic paraparesis/HTLV-I associated myelopathy and HTLV-I infection.
Gessain A
J Neurovirol; 1996 Oct; 2(5):299-306. PubMed ID: 8912206
[TBL] [Abstract][Full Text] [Related]
40. Mediators of central nervous system damage during the progression of human T-cell leukemia type I-associated myelopathy/tropical spastic paraparesis.
Barmak K; Harhaj EW; Wigdahl B
J Neurovirol; 2003 Oct; 9(5):522-9. PubMed ID: 13129766
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
